Informed consent statements were not included in the published version of the following articles that appeared in previous issues of Journal of Interventional Medicine. The appropriate informed consent statements, provided by the respective authors, are included below:
-
1.
“TILA-TACE - an approach for effective local control of hepatocellular carcinoma” (2018, 1:58–63). Informed consent: written informed consent was obtained from all individual patients included in the study.
-
2.
“Endovascular treatment for left innominate vein aneurysm: Case report and literature review” (2019, 2:35–37). Informed consent: written informed consent was obtained from all individual patients included in the study.
-
3.
“A modified wire-loop snare technique for the retrieval of a large cardiac cement embolus caused by cement leakage after percutaneous vertebroplasty” (2019, 2:38–41). Informed consent: written informed consent was obtained from the patient included in the study.
-
4.
“Superselective transcatheter arterial embolization to control renal hemorrhage after partial nephrectomy for renal tumors: A report of 9 cases and a literature review” (2019, 2:134–138). Informed consent: written informed consent was obtained from all individual patients included in the study.
-
5.
“Treatment of inadvertent subclavian artery cannulation with a percutaneous vascular closure device” (2019, 2:164–165). Informed consent: written informed consent was obtained from the patient included in the study.
-
6.
“Preoperative evaluation of transcatheter aortic valve replacement with assistance of 3D printing technique: Reanalysis of 4 death cases” (2019, 2:166–170). Informed consent: written informed consent was waived due to the retrospective nature of the study.
-
7.
“Open surgical treatment for rare epithelioid hemangioendothelioma of the common femoral vein” (2019, 2:178–180). Informed consent: written informed consent was obtained from the patient included in the study.
-
8.
“Secondary sclerosing cholangitis from percutaneous transhepatic biliary drainage in a patient with gallbladder cancer after surgery: A case report” (Volume 3, 2020, 58–59). Informed consent: written informed consent was obtained from the patient included in the study.
-
9.
“Retroperitoneal hematoma after implantation of double inferior vena cava filters” (2018, 1:252–256). Informed consent: written informed consent was obtained from the patient included in the study.
-
10.
“Clinical study of transcatheter occlusion in treating ventricular septal defect combined with right coronary cusp bulge” (2018, 1:205–211). Informed consent: written informed consent was obtained from all patients' families or legal representatives.
-
11.
“Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency” (2018, 1:234–239). Informed consent: written informed consent was waived due to the retrospective nature of the study.
-
12.
“Safety and efficacy of microwave ablation for periductal hepatocellular carcinoma with intraductal cooling of the central bile ducts through a percutaneous transhepatic cholangial drainage tube” (2019, 2:84–90). Informed consent: written informed consent was obtained from all individual patients included in the study.